Triple negative breast cancer: clinicopathological characteristics and treatment strategies

被引：11

作者：

Akiyama, Futoshi ^{[2
]}

Iwase, Hirotaka ^{[1
]}

机构：

[1] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Breast & Endocrine Surg, Kumamoto 8608556, Japan

[2] Inst Canc Res, Dept Pathol, Koto Ku, Tokyo 1358550, Japan

来源：

BREAST CANCER | 2009年 / 16卷 / 04期

关键词：

Triple negative breast cancer; Basal-like tumor;

D O I：

10.1007/s12282-009-0140-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Triple negative breast cancer (TNBC) is defined as a subtype that is negative for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2. We introduce the theme of the special issue concerning clinicopathological characteristics and prospective treatment strategies of TNBC. This special issue consists of five conference papers that have been agreed on by the speakers and the commentator of the symposium of the 16th Annual Meeting of the Japanese Breast Cancer Society in September 2008 in Osaka.

引用

页码：252 / 253

页数：2

共 3 条

[1] Clinical importance of estrogen receptor-β evaluation in breast cancer patients treated with adjuvant tamoxifen therapy [J].

Honma, Naoko ;

Horii, Rie ;

Iwase, Takuji ;

Saji, Shigehira ;

Younes, Mamoun ;

Takubo, Kaiyo ;

Matsuura, Masaaki ;

Ito, Yoshinori ;

Akiyama, Futoshi ;

Sakamoto, Goi .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3727-3734

[2] Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance [J].

Kobayashi, Shunzo .

BREAST CANCER, 2008, 15 (02) :153-158

[3]

Yamamoto Y, 2008, JPN J BREAST CANC, V23, P75

← 1 →